688065 凯赛生物
已收盘 03-20 15:00:00
资讯
新帖
简况
凯赛生物跌3.16% 2020年上市即巅峰2度募资合计115亿
中金财经 · 03-18
凯赛生物跌3.16% 2020年上市即巅峰2度募资合计115亿
凯赛生物跌3.99% 2020年上市即巅峰2度募资合计115亿
中金财经 · 03-17
凯赛生物跌3.99% 2020年上市即巅峰2度募资合计115亿
股市必读：凯赛生物发布2025年度业绩快报，盈利5.657亿元
证券之星 · 03-02
股市必读：凯赛生物发布2025年度业绩快报，盈利5.657亿元
每周股票复盘：凯赛生物（688065）2025年净利5.657亿增15.7%
证券之星 · 03-01
每周股票复盘：凯赛生物（688065）2025年净利5.657亿增15.7%
凯赛生物（688065）披露2025年度业绩快报，2月27日股价上涨0.55%
证券之星 · 02-27
凯赛生物（688065）披露2025年度业绩快报，2月27日股价上涨0.55%
每周股票复盘：凯赛生物（688065）现折价13.26%大宗交易
证券之星 · 02-08
每周股票复盘：凯赛生物（688065）现折价13.26%大宗交易
2月2日凯赛生物跌7.77%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 02-02
2月2日凯赛生物跌7.77%，博时上证科创板新材料ETF基金重仓该股
凯赛生物跌3.6% 2020年上市即巅峰2度募资合计115亿
中金财经 · 01-15
凯赛生物跌3.6% 2020年上市即巅峰2度募资合计115亿
1月13日凯赛生物涨12.14%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 01-13
1月13日凯赛生物涨12.14%，博时上证科创板新材料ETF基金重仓该股
1月6日凯赛生物涨8.09%，博时上证科创板新材料ETF基金重仓该股
证券之星 · 01-06
1月6日凯赛生物涨8.09%，博时上证科创板新材料ETF基金重仓该股
每周股票复盘：凯赛生物（688065）规范运作无违规情形
证券之星 · 01-02
每周股票复盘：凯赛生物（688065）规范运作无违规情形
凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%
证券日报 · 2025-11-25
凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%
凯赛生物：公司2025年前三季度产品销售量同比增长
证券日报 · 2025-11-25
凯赛生物：公司2025年前三季度产品销售量同比增长
11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元
证券之星 · 2025-11-25
11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元
每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户
证券之星 · 2025-11-23
每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户
凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%
证券之星 · 2025-11-21
凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%
凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%
证券之星 · 2025-11-19
凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%
凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》
证券日报 · 2025-10-31
凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》
凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%
证券之星 · 2025-10-31
凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%
图解凯赛生物三季报：第三季度单季净利润同比增长45.30%
证券之星 · 2025-10-31
图解凯赛生物三季报：第三季度单季净利润同比增长45.30%
加载更多
公司概况
公司名称：
上海凯赛生物技术股份有限公司
所属行业：
化学纤维制造业
上市日期：
2020-08-12
主营业务：
上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。
发行价格：
133.45
{"stockData":{"symbol":"688065","market":"SH","secType":"STK","nameCN":"凯赛生物","latestPrice":49,"timestamp":1773990000000,"preClose":51.24,"halted":0,"volume":7525913,"delay":0,"changeRate":-0.0437,"floatShares":583000000,"shares":721000000,"eps":0.8242,"marketStatus":"已收盘","change":-2.24,"latestTime":"03-20 15:00:00","open":51.24,"high":51.47,"low":49,"amount":376000000,"amplitude":0.0482,"askPrice":49.02,"askSize":7,"bidPrice":49,"bidSize":522,"shortable":0,"etf":0,"ttmEps":0.8242,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":51.24,"symbolType":"stock_kcb","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":56.36,"lowLimit":46.12,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":721289794,"isCdr":false,"pbRate":2.01,"roa":"--","peRate":59.451589,"roe":"2.89%","epsLYR":0.84,"committee":0.801874,"marketValue":35343000000,"turnoverRate":0.0129,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-03-23。","afterMarket":{"amount":111377,"volume":2273,"close":49,"buyVolume":0,"sellVolume":1727,"time":1773992037559,"indexStatus":"已收盘 03-20 15:30:00","preClose":51.24},"floatMarketCap":28586000000},"requestUrl":"/m/hq/s/688065","defaultTab":"news","newsList":[{"id":"2620342232","title":"凯赛生物跌3.16% 2020年上市即巅峰2度募资合计115亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2620342232","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620342232?lang=zh_cn&edition=full","pubTime":"2026-03-18 18:16","pubTimestamp":1773828969,"startTime":"0","endTime":"0","summary":"中国经济网北京3月18日讯 凯赛生物 今日股价下跌，截至收盘报52.44元，跌幅3.16%。 上市首日，凯赛生物盘中最高价198元，为该股上市以来最高价。 凯赛生物首次公开发行股票募集资金总额556,062.10万元，募集资金净额为527,999.38万元。 凯赛生物上述2次募集资金合计114.87亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260318/32078742.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2620601447","title":"凯赛生物跌3.99% 2020年上市即巅峰2度募资合计115亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2620601447","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620601447?lang=zh_cn&edition=full","pubTime":"2026-03-17 16:54","pubTimestamp":1773737673,"startTime":"0","endTime":"0","summary":"中国经济网北京3月17日讯 凯赛生物 今日股价下跌，截至收盘报54.15元，跌幅3.99%。 凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。 上市首日，凯赛生物盘中最高价198元，为该股上市以来最高价。 凯赛生物上述2次募集资金合计114.87亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260317/32074824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2616587696","title":"股市必读：凯赛生物发布2025年度业绩快报，盈利5.657亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616587696","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616587696?lang=zh_cn&edition=full","pubTime":"2026-03-02 03:02","pubTimestamp":1772391738,"startTime":"0","endTime":"0","summary":"来自业绩披露要点：凯赛生物预计2025年归属净利润盈利5.657亿元，同比增长15.7%。来自公司公告汇总：凯赛生物2025年度营业收入达32.95亿元，同比增长11.41%，净资产较期初增长53.86%主要因完成定向增发募资59.15亿元。公司公告汇总2025年度业绩快报公告上海凯赛生物技术股份有限公司发布2025年度业绩快报，营业收入329,544.89万元，同比增长11.41%；营业利润63,509.18万元，同比增长15.14%；归属于上市公司股东的净利润56,572.04万元，同比增长15.70%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200001371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2616455838","title":"每周股票复盘：凯赛生物（688065）2025年净利5.657亿增15.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616455838","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616455838?lang=zh_cn&edition=full","pubTime":"2026-03-01 02:39","pubTimestamp":1772303950,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，凯赛生物报收于54.68元，较上周的53.08元上涨3.01%。本周，凯赛生物2月25日盘中最高价报56.68元。本周关注点来自业绩披露要点：凯赛生物2025年归属净利润5.657亿元，同比增长15.7%。公司公告汇总上海凯赛生物技术股份有限公司发布2025年度业绩快报，营业收入329,544.89万元，同比增长11.41%；营业利润63,509.18万元，同比增长15.14%；归属于上市公司股东的净利润56,572.04万元，同比增长15.70%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2614175857","title":"凯赛生物（688065）披露2025年度业绩快报，2月27日股价上涨0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2614175857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614175857?lang=zh_cn&edition=full","pubTime":"2026-02-27 23:13","pubTimestamp":1772205193,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，凯赛生物报收于54.68元，较前一交易日上涨0.55%，最新总市值为394.4亿元。该股当日开盘54.24元，最高55.1元，最低53.93元，成交额达1.82亿元，换手率为0.57%。近日，上海凯赛生物技术股份有限公司发布2025年度业绩快报，营业收入329,544.89万元，同比增长11.41%；营业利润63,509.18万元，同比增长15.14%；归属于上市公司股东的净利润56,572.04万元，同比增长15.70%。基本每股收益0.83元，同比下降1.19%；加权平均净资产收益率3.52%，同比减少0.79个百分点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022700043149.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2609525147","title":"每周股票复盘：凯赛生物（688065）现折价13.26%大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2609525147","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2609525147?lang=zh_cn&edition=full","pubTime":"2026-02-08 02:07","pubTimestamp":1770487632,"startTime":"0","endTime":"0","summary":"截至2026年2月6日收盘，凯赛生物报收于54.21元，较上周的58.15元下跌6.78%。本周，凯赛生物2月2日盘中最高价报58.0元。2月6日盘中最低价报53.23元。凯赛生物当前最新总市值391.01亿元，在化学制品板块市值排名8/170，在两市A股市值排名521/5186。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020800000595.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2608518208","title":"2月2日凯赛生物跌7.77%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2608518208","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608518208?lang=zh_cn&edition=full","pubTime":"2026-02-02 16:40","pubTimestamp":1770021649,"startTime":"0","endTime":"0","summary":"证券之星消息，2月2日凯赛生物跌7.77%，收盘报53.63元，换手率1.79%，成交量10.44万手，成交额5.76亿元。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共6家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.29亿元，最新净值0.9501，较上一交易日下跌0.85%，近一年上涨72.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020200023399.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399001","000688.SH","159967","000905.SH","510300","512510","512880","510880","515890","000300.SH","BK0208","688065","399006"],"gpt_icon":0},{"id":"2603677006","title":"凯赛生物跌3.6% 2020年上市即巅峰2度募资合计115亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2603677006","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603677006?lang=zh_cn&edition=full","pubTime":"2026-01-15 16:35","pubTimestamp":1768466115,"startTime":"0","endTime":"0","summary":"中国经济网北京1月15日讯 凯赛生物 今日收报57.62元，跌幅3.60%。 凯赛生物于2020年8月12日在上交所科创板上市，公开发行股份总数为4,166.8198万股，占发行后股份总数的10.00%，发行价格为133.45元/股，保荐人为中信证券股份有限公司，保荐代表人为先卫国、黄艺彬。 上市首日，凯赛生物盘中最高价198元，为该股上市以来最高价。 凯赛生物上市募集资金总额556,062.10万元，募集资金净额为527,999.38万元。 凯赛生物上述2次募集资金合计114.87亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260115/31945144.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2603505136","title":"1月13日凯赛生物涨12.14%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2603505136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603505136?lang=zh_cn&edition=full","pubTime":"2026-01-13 15:35","pubTimestamp":1768289736,"startTime":"0","endTime":"0","summary":"证券之星消息，1月13日凯赛生物涨12.14%创60日新高，收盘报62.24元，换手率3.05%，成交量17.78万手，成交额10.93亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.91亿元，最新净值0.9894，较上一交易日上涨3.62%，近一年上涨88.06%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011300020420.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000905.SH","BK0208","510300","512510","399006","688065","512880","399001","000688.SH","515890","000300.SH","510880","159967"],"gpt_icon":0},{"id":"2601864956","title":"1月6日凯赛生物涨8.09%，博时上证科创板新材料ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2601864956","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601864956?lang=zh_cn&edition=full","pubTime":"2026-01-06 15:35","pubTimestamp":1767684954,"startTime":"0","endTime":"0","summary":"证券之星消息，1月6日凯赛生物涨8.09%创60日新高，收盘报54.93元，换手率1.68%，成交量9.78万手，成交额5.24亿元。根据2025基金Q3季报公募基金重仓股数据，重仓该股的公募基金共4家，其中持有数量最多的公募基金为博时基金的博时上证科创板新材料ETF。博时上证科创板新材料ETF目前规模为2.91亿元，最新净值0.8864，较上一交易日上涨2.78%，近一年上涨67.69%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600020366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["399006","515890","BK0208","000905.SH","510300","688065","510880","512510","159967","588010","399001","000688.SH","000300.SH","512880"],"gpt_icon":0},{"id":"2600351660","title":"每周股票复盘：凯赛生物（688065）规范运作无违规情形","url":"https://stock-news.laohu8.com/highlight/detail?id=2600351660","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600351660?lang=zh_cn&edition=full","pubTime":"2026-01-02 01:56","pubTimestamp":1767290170,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，凯赛生物报收于50.21元，较上周的48.31元上涨3.93%。本周，凯赛生物12月26日盘中最高价报50.28元。本周关注点公司公告汇总：凯赛生物2025年持续督导检查显示规范运作，未发现违规情形公司公告汇总招商证券作为保荐人，对凯赛生物2025年1月1日至现场检查期间的规范运作情况进行了现场检查。经检查，凯赛生物在上述各方面运作符合相关监管要求，未发现违规情形，亦无须向监管部门报告的重大事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010200000419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2586478396","title":"凯赛生物：公司2025年前三季度营业收入25.45亿元，同比增长14.90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586478396","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586478396?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:33","pubTimestamp":1764070380,"startTime":"0","endTime":"0","summary":"证券日报网讯凯赛生物11月25日在互动平台回答投资者提问时表示，公司2025年前三季度营业收入25.45亿元，同比增长14.90%，净利润4.51亿元，同比增长30.56%。公司积极推动系列生物基聚酰胺及其复合材料的应用开发，会同招商局集团及各领域下游合作伙伴，合力推动生物制造产业生态圈的建设。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmit4746603.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmit4746603.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065"],"gpt_icon":0},{"id":"2586147834","title":"凯赛生物：公司2025年前三季度产品销售量同比增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2586147834","media":"证券日报 ","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586147834?lang=zh_cn&edition=full","pubTime":"2025-11-25 19:33","pubTimestamp":1764070380,"startTime":"0","endTime":"0","summary":"郑重声明：东方财富发布此内容旨在传播更多信息，与本站立场无关，不构成投资建议。据此操作，风险自担。 \n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmiw4026217.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-11-25/doc-infyrmiw4026217.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2586262444","title":"11月25日凯赛生物现1笔折价20.85%的大宗交易 合计成交4324.06万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2586262444","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586262444?lang=zh_cn&edition=full","pubTime":"2025-11-25 17:52","pubTimestamp":1764064367,"startTime":"0","endTime":"0","summary":"证券之星消息，11月25日凯赛生物发生大宗交易，交易数据如下：大宗交易成交价格38.46元，相对当日收盘价折价20.85%，成交112.43万股，成交金额4324.06万元，买方营业部为长城证券股份有限公司重庆新南路证券营业部，卖方营业部为长城证券股份有限公司重庆新南路证券营业部。近三个月该股共发生1笔大宗交易，合计成交1.12万手，折价成交1笔。截至2025年11月25日收盘，凯赛生物报收于48.59元，上涨1.08%，换手率0.59%，成交量3.46万手，成交额1.69亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112500027257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2585210687","title":"每周股票复盘：凯赛生物（688065）2025年员工持股计划完成非交易过户","url":"https://stock-news.laohu8.com/highlight/detail?id=2585210687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585210687?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:24","pubTimestamp":1763843050,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，凯赛生物报收于47.9元，较上周的50.2元下跌4.58%。公司公告汇总关于2025年员工持股计划首次授予部分非交易过户完成的公告上海凯赛生物技术股份有限公司2025年员工持股计划首次授予部分已完成非交易过户。该部分股份已于2025年11月17日由公司回购专用证券账户非交易过户至员工持股计划专用账户。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001246.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2585141363","title":"凯赛生物（688065）披露高级管理人员变更及选举副董事长公告，11月21日股价下跌2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141363","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585141363?lang=zh_cn&edition=full","pubTime":"2025-11-21 22:49","pubTimestamp":1763736592,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，凯赛生物报收于47.9元，较前一交易日下跌2.56%，最新总市值为345.5亿元。该股当日开盘48.89元，最高49.88元，最低47.65元，成交额达2.1亿元，换手率为0.75%。近日，凯赛生物发布公告称，公司于2025年11月21日召开第三届董事会第四次会议，同意XIUCAI LIU（刘修才）先生辞去公司总裁职务，其辞职报告自送达董事会之日起生效。此外，董事会选举臧慧卿女士为第三届董事会副董事长，任期至本届董事会任期届满。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100040982.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2584294790","title":"凯赛生物（688065）披露2025年员工持股计划首次授予部分非交易过户完成，11月19日股价下跌0.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584294790","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584294790?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:32","pubTimestamp":1763562738,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，凯赛生物报收于49.64元，较前一交易日下跌0.06%，最新总市值为358.05亿元。近日，凯赛生物发布关于2025年员工持股计划首次授予部分非交易过户完成的公告。该部分股份已于2025年11月17日由公司回购专用证券账户非交易过户至员工持股计划专用账户。员工持股计划存续期为48个月，标的股票分两期解锁，每期解锁比例均为50%，解锁时点分别为股票过户完成之日起满12个月、24个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2579149394","title":"凯赛生物：关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2579149394","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579149394?lang=zh_cn&edition=full","pubTime":"2025-10-31 22:09","pubTimestamp":1761919740,"startTime":"0","endTime":"0","summary":"证券日报网讯凯赛生物10月31日在互动平台回答投资者提问时表示，关于募投项目延期事项详见公司于2025年9月30日披露的《关于部分募投项目延期的公告》（公告编号：2025-050）。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvvcym5382686.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvvcym5382686.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688065","BK0208"],"gpt_icon":0},{"id":"2579530451","title":"凯赛生物(688065)9月30日股东户数1.5万户，较上期增加28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579530451","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579530451?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:32","pubTimestamp":1761903174,"startTime":"0","endTime":"0","summary":"证券之星消息，近日凯赛生物披露，截至2025年9月30日公司股东户数为1.5万户，较6月30日增加3280.0户，增幅为28.0%。在化学制品行业个股中，凯赛生物股东户数低于行业平均水平，截至9月30日，化学制品行业平均股东户数为2.8万户。从股价来看，2025年6月30日至2025年9月30日，凯赛生物区间涨幅为11.41%，在此期间股东户数增加3280.0户，增幅为28.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100036776.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0208","688065"],"gpt_icon":0},{"id":"2579402175","title":"图解凯赛生物三季报：第三季度单季净利润同比增长45.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579402175","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579402175?lang=zh_cn&edition=full","pubTime":"2025-10-31 02:48","pubTimestamp":1761850133,"startTime":"0","endTime":"0","summary":"证券之星消息，凯赛生物2025年三季报显示，前三季度公司主营收入25.45亿元，同比上升14.9%；归母净利润4.51亿元，同比上升30.56%；扣非净利润4.29亿元，同比上升27.83%；其中2025年第三季度，公司单季度主营收入8.74亿元，同比上升13.43%；单季度归母净利润1.42亿元，同比上升45.3%；单季度扣非净利润1.32亿元，同比上升38.25%；负债率9.5%，投资收益-422.24万元，财务费用-9898.76万元，毛利率34.75%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100003059.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688065"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774110254495,"stockEarnings":[{"period":"1week","weight":-0.1341},{"period":"1month","weight":-0.0769},{"period":"3month","weight":0.0143},{"period":"6month","weight":-0.0555},{"period":"1year","weight":-0.0173},{"period":"ytd","weight":-0.0161}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海凯赛生物技术股份有限公司","boardCode":"AI0028","boardName":"化学纤维制造业","stockholders":"14994人(较上一季度增加28.00%)","perCapita":"38907股","listingDate":"2020-08-12","address":"上海市浦东新区中国(上海)自由贸易试验区蔡伦路1690号5幢4楼","registeredCapital":"72128万元","survey":" 上海凯赛生物技术股份有限公司的主营业务是新型生物基材料的研发、生产及销售。公司的主要产品是系列生物法长链二元酸（DC10-DC18）、生物基戊二胺、系列生物基聚酰胺、生物基连续纤维热塑型复合材料（Bio-PPACFRT）。","listedPrice":133.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"凯赛生物,688065,凯赛生物股票,凯赛生物股票老虎,凯赛生物股票老虎国际,凯赛生物行情,凯赛生物股票行情,凯赛生物股价,凯赛生物股市,凯赛生物股票价格,凯赛生物股票交易,凯赛生物股票购买,凯赛生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"凯赛生物(688065)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供凯赛生物(688065)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}